Showing results (31-40 of 2,396) with videos related to

Sort By:
Pageof 240
Breast Cancer (Tokyo, Japan)|April 21, 2011
Versican G1 and G3 domains are upregulated and latent transforming growth factor-β binding protein-4 is downregulated in breast cancer stromaYuko Takahashi, Hiroko Kuwabara, Masahiko Yoneda, et al.
Breast Cancer (Tokyo, Japan)|March 19, 2011
Parenchymal leiomyoma of the breast: a case report with special reference to magnetic resonance imaging findings and an update review of literatureShigeki Minami, Shigetoshi Matsuo, Takashi Azuma, et al.
Breast Cancer (Tokyo, Japan)|April 6, 2011
Radiographic features for triple negative ductal carcinoma in situ of the breastYasuyuki Kojima, Hiroko Tsunoda, Satoshi Honda, et al.
Breast Cancer (Tokyo, Japan)|March 10, 2021
Breast cancer preoperative 18FDG-PET, overall survival prognostic separation compared with the lymph node ratioVincent Vinh-Hung, Hendrik Everaert, Olena Gorobets, et al.
Breast Cancer (Tokyo, Japan)|July 22, 2019
Taxane-based combinations as adjuvant chemotherapy for node-positive ER-positive breast cancer based on 2004-2009 data from the Breast Cancer Registry of the Japanese Breast Cancer SocietyTakashi Hojo, Norikazu Masuda, Takayuki Iwamoto, et al.
Breast Cancer (Tokyo, Japan)|April 18, 2024
French national survey on breast cancer care: caregiver and patient viewsChristine Rousset-Jablonski, Barbara Lortal, Sophie Lantheaume, et al.
Breast Cancer (Tokyo, Japan)|April 20, 2024
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational studyTetsuhiro Yoshinami, Shigenori E Nagai, Masaya Hattori, et al.
Breast Cancer (Tokyo, Japan)|August 25, 2014
Mammary ductoscopy and watchful follow-up substitute microdochectomy in patients with bloody nipple dischargeMasujiro Makita, Futoshi Akiyama, Naoya Gomi, et al.
Breast Cancer (Tokyo, Japan)|March 17, 2016
Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancerTímea Tőkés, Kornélia Kajáry, Gyöngyvér Szentmártoni, et al.
Breast Cancer (Tokyo, Japan)|February 23, 2012
A phase 2 study of sequential neoadjuvant chemotherapy with gemcitabine and doxorubicin followed by gemcitabine and cisplatin in patients with large or locally advanced operable breast cancer: results from long-term follow-upPramod K Julka, Raju T Chacko, Shona Nag, et al.
Pageof 240